"Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial"
written by Timothy Nicholas, Sridhar Duvvuri, Claire Leurent, David Raunig, Tracey Rapp, Phil Iredale, Carolyn Rowinski, Robert Carr, Patrick Roberts, Athan Spiros, Hugo Geerts,
published by Advances in Alzheimer's Disease, Vol.2 No.3, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Therapeutic modulators of the serotonin 5-HT4 receptor: a patent review (2014-present)
2020
[2] Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach
2020
[3] Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
2020
[4] Neuronal Circuit-Based Computer Modeling as a Phenotypic Strategy for CNS R&D
2019
[5] Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities
2019
[6] Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
Journal of Psychopharmacology, 2018
[7] Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseases
Expert Review of Clinical Pharmacology, 2018
[8] Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model
2018
[9] Knowledge-driven computational modeling in Alzheimer's research: Current state and future trends
Alzheimer's & Dementia, 2017
[10] Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's Disease
European Journal of Pharmacology, 2017
[11] Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment
2017
[12] Knowledge-driven computational modeling in Alzheimer's disease research: Current state and future trends
2017
[13] Semi-mechanistic computer simulation of psychotic symptoms in schizophrenia with a model of a humanized cortico-striatal-thalamocortical loop
European Neuropsychopharmacology, 2017
[14] The promises of quantitative systems pharmacology modelling for drug development
Computational and Structural Biotechnology Journal, 2016
[15] Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge
Alzheimer's & Dementia, 2016
[16] A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease
Frontiers in pharmacology, 2016
[17] Big data to smart data in AD: Real-world examples of advanced modeling and simulation
Alzheimer's & Dementia, 2016
[18] From big data to smart data in Alzheimer's disease. The brain health modeling initiative to foster actionable knowledge
Alzheimer's & Dementia, 2016
[19] Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
Frontiers in pharmacology, 2015
[20] Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient …
Frontiers in Pharmacology, 2015
[21] SF 424 (R&R) APPLICATION FOR FEDERAL ASSISTANCE Page 2
2015
[22] Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery
Future medicinal chemistry, 2015
[23] Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient …
Frontiers in Pharmacology, 2014
[24] A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition …
Frontiers in pharmacology, 2014
[25] A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance
Frontiers in pharmacology, 2014
[26] Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward
Future medicinal chemistry, 2014
[27] Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach
[28] Most Popular